167 related articles for article (PubMed ID: 30158525)
1. Novel β-phenylacrylic acid derivatives exert anti-cancer activity by inducing Src-mediated apoptosis in wild-type KRAS colon cancer.
Kim SJ; Noh TH; Son S; Kim DH; Kim W; Lee Y; Choo J; Heo G; Kim MJ; Chung HY; Jung Y; Jung JH; Moon HR; Im E
Cell Death Dis; 2018 Aug; 9(9):877. PubMed ID: 30158525
[TBL] [Abstract][Full Text] [Related]
2. The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling.
Asbagh LA; Vazquez I; Vecchione L; Budinska E; De Vriendt V; Baietti MF; Steklov M; Jacobs B; Hoe N; Singh S; Imjeti NS; Zimmermann P; Sablina A; Tejpar S
Oncotarget; 2014 Oct; 5(20):10070-83. PubMed ID: 25301722
[TBL] [Abstract][Full Text] [Related]
3. Activated Src and Ras induce gefitinib resistance by activation of signaling pathways downstream of epidermal growth factor receptor in human gallbladder adenocarcinoma cells.
Qin B; Ariyama H; Baba E; Tanaka R; Kusaba H; Harada M; Nakano S
Cancer Chemother Pharmacol; 2006 Nov; 58(5):577-84. PubMed ID: 16532343
[TBL] [Abstract][Full Text] [Related]
4. Aplidin induces apoptosis in human cancer cells via glutathione depletion and sustained activation of the epidermal growth factor receptor, Src, JNK, and p38 MAPK.
Cuadrado A; Garcia-Fernandez LF; Gonzalez L; Suarez Y; Losada A; Alcaide V; Martinez T; Fernandez-Sousa JM; Sanchez-Puelles JM; Munoz A
J Biol Chem; 2003 Jan; 278(1):241-50. PubMed ID: 12414812
[TBL] [Abstract][Full Text] [Related]
5. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
Kline CL; Irby RB
Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
[TBL] [Abstract][Full Text] [Related]
6. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
7. A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers.
Šuštić T; van Wageningen S; Bosdriesz E; Reid RJD; Dittmar J; Lieftink C; Beijersbergen RL; Wessels LFA; Rothstein R; Bernards R
Genome Med; 2018 Nov; 10(1):90. PubMed ID: 30482246
[TBL] [Abstract][Full Text] [Related]
8. Interacting post-muscarinic receptor signaling pathways potentiate matrix metalloproteinase-1 expression and invasion of human colon cancer cells.
Said AH; Hu S; Abutaleb A; Watkins T; Cheng K; Chahdi A; Kuppusamy P; Saxena N; Xie G; Raufman JP
Biochem J; 2017 Feb; 474(5):647-665. PubMed ID: 28008134
[TBL] [Abstract][Full Text] [Related]
9. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
10. Cetuximab-induced MET activation acts as a novel resistance mechanism in colon cancer cells.
Song N; Liu S; Zhang J; Liu J; Xu L; Liu Y; Qu X
Int J Mol Sci; 2014 Apr; 15(4):5838-51. PubMed ID: 24714091
[TBL] [Abstract][Full Text] [Related]
11. The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Yang Z; Bagheri-Yarmand R; Wang RA; Adam L; Papadimitrakopoulou VV; Clayman GL; El-Naggar A; Lotan R; Barnes CJ; Hong WK; Kumar R
Clin Cancer Res; 2004 Jan; 10(2):658-67. PubMed ID: 14760089
[TBL] [Abstract][Full Text] [Related]
12. Sprouty2 protein enhances the response to gefitinib through epidermal growth factor receptor in colon cancer cells.
Feng YH; Tsao CJ; Wu CL; Chang JG; Lu PJ; Yeh KT; Shieh GS; Shiau AL; Lee JC
Cancer Sci; 2010 Sep; 101(9):2033-8. PubMed ID: 20624167
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated delivery of anti-KRAS-siRNA in vivo overcomes therapy resistance in colon cancer.
Bäumer S; Bäumer N; Appel N; Terheyden L; Fremerey J; Schelhaas S; Wardelmann E; Buchholz F; Berdel WE; Müller-Tidow C
Clin Cancer Res; 2015 Mar; 21(6):1383-94. PubMed ID: 25589625
[TBL] [Abstract][Full Text] [Related]
14. Combination therapy with KRAS siRNA and EGFR inhibitor AZD8931 suppresses lung cancer cell growth in vitro.
Zarredar H; Pashapour S; Ansarin K; Khalili M; Baghban R; Farajnia S
J Cell Physiol; 2019 Feb; 234(2):1560-1566. PubMed ID: 30132854
[TBL] [Abstract][Full Text] [Related]
15. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
16. Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells.
Lou YF; Zou ZZ; Chen PJ; Huang GB; Li B; Zheng DQ; Yu XR; Luo XY
PLoS One; 2014; 9(5):e97719. PubMed ID: 24874286
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib enhances human colon cancer cells to TRAIL-induced apoptosis of via autophagy- and JNK-mediated death receptors upregulation.
Chen L; Meng Y; Guo X; Sheng X; Tai G; Zhang F; Cheng H; Zhou Y
Apoptosis; 2016 Nov; 21(11):1291-1301. PubMed ID: 27629794
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone induces apoptosis in human colon cancer HCT116 cells through inactivation of STAT3 by blocking JAK2- and Src‑mediated phosphorylation of EGF receptor tyrosine kinase.
Kundu J; Choi BY; Jeong CH; Kundu JK; Chun KS
Oncol Rep; 2014 Aug; 32(2):821-8. PubMed ID: 24890449
[TBL] [Abstract][Full Text] [Related]
19. Selective involvement of p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK activation.
Kodama H; Fukuda K; Takahashi E; Tahara S; Tomita Y; Ieda M; Kimura K; Owada KM; Vuori K; Ogawa S
Hypertension; 2003 Jun; 41(6):1372-9. PubMed ID: 12719447
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the Src family kinase yes in bile salt-induced apoptosis.
Reinehr R; Becker S; Wettstein M; Häussinger D
Gastroenterology; 2004 Nov; 127(5):1540-57. PubMed ID: 15521021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]